Advertisement

Topics

ImQuest BioSciences Inc. Company Profile

17:26 EDT 21st September 2017 | BioPortfolio


News Articles [664 Associated News Articles listed on BioPortfolio]

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo ...

http://dailystocktracker.com/register/ Apricus Biosciences  On Tuesday, shares in San Diego, Californiaheadquartered Apricus Biosciences Inc. recorded a trading volume of 128,247 shares. The stoc...

Reviewing Catalyst Biosciences

Catalyst Biosciences and Fortress Biotech are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valu...

Pressure BioSciences, Inc. to Present at the 19th Annual Rodman Renshaw Global Investment ...

SOUTH EASTON, MA--(Marketwired - Sep 11, 2017) - Pressure BioSciences, Inc. ( OTCQB : PBIO) ("PBI" and the "Company"), a leader in the Read more...

Deals this week: Selecta Biosciences, bluebird bio, TransGenic

Selecta Biosciences intends to raise $50m through private placement of shares of its common stock to be subscribed to by new and existing institutional investors and one of the company’s board of di...

Clasado Biosciences Brings Its Revolutionary Prebiotic Supplement to SupplySide West

JERSEY, CHANNEL ISLANDS--(Marketwired - Aug 25, 2017) - Clasado Biosciences, the international biotechnology company and global leader in the research of gut mediated wellness Read more...

Pacific Biosciences Of California Prices Offering At $3.10/Share

WASHINGTON (dpa-AFX) - Pacific Biosciences of California, Inc. (PACB) has offered to sell 15.42 million shares of its common stock to the public at a price of $3.10 each. The underwriter has a 30-...

SYGNIS schließt Übernahme von Innova Biosciences ab

Die SYGNIS AG (ISIN: DE000A1RFM03) hat die Akquisition von Innova Biosciences Ltd., einem britischen Spezialisten für Biokonjugationstechnologien und -Services, erfolgreich abgeschlossen. Das Heide.....

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

The purpose of this study is describe the safety and single-dose pharmacokinetics of rectally-administered IQP (ImQuest Pharmaceuticals)-0528 (DuoGel) in plasma, rectal tissue biopsies, va...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [341 Associated Companies listed on BioPortfolio]

ImQuest Life Sciences, Inc.

ImQuest BioSciences, a privately held U.S. company located in Frederick, Maryland is a leading provider of anti-infective therapeutic and microbicide development and anti-cancer services to the biotec...

ImQuest BioSciences Inc.

ImQuest BioSciences

ImQuest BioSciences, Inc. is one of the world's leading providers of services ranging from anti - infective drug and vaccine discovery and complete preclinical therapeutic development to basic initiat...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

More Information about "ImQuest BioSciences Inc." on BioPortfolio

We have published hundreds of ImQuest BioSciences Inc. news stories on BioPortfolio along with dozens of ImQuest BioSciences Inc. Clinical Trials and PubMed Articles about ImQuest BioSciences Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ImQuest BioSciences Inc. Companies in our database. You can also find out about relevant ImQuest BioSciences Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record